How Pharma Leaders Are Rethinking Evidence Generation in the AI Era
Learn what organizations must do to balance speed, transparency, governance, and innovation in an increasingly data-driven and AI-reliant environment.
Where Treatment Slows in Metastatic NSCLC: A Real-World Data Analysis of Care Delays and Access Barriers
As regulators around the world grow more comfortable with real-world data (RWD) and AI-enabled evidence generation, pharma companies are rethinking how, and when, they build evidence.
Pharma’s New Regulatory Reality: Building Evidence for Launch and Beyond
As regulators around the world grow more comfortable with real-world data (RWD) and AI-enabled evidence generation, pharma companies are rethinking how, and when, they build evidence.
Smarter Data, Better Outcomes: How Real-World Data Is Transforming Evidence Generation Across the Product Lifecycle
As real-world data (RWD) becomes more central to healthcare decision making, evidence generation is playing an increasingly important role, from early identification to treatment optimization and beyond. But its impact goes far beyond supporting regulatory approval or market access. We caught up with Chris Harvey, VP of RWD Product and Offering Management at Norstella, Panalgo’s […]
Data Without Borders: How IHD Cloud Simplifies Global Data Access
Accessing real-world data across international borders has long been a headache for life sciences companies. Data residency laws, privacy concerns, and siloed systems have historically slowed down insights and delayed market decisions. But Panalgo’s IHD Cloud is changing the game. We spoke with Erik Maul, Senior Director of RWE Partnerships at Panalgo, to find out […]
Beyond Data Silos: Centralizing Real-World Data with IHD Cloud
Accessing and leveraging real-world data (RWD) is a persistent challenge for life sciences companies. Data silos, inefficiencies, and complex workflows often hinder organizations from fully utilizing their data assets to drive insights and decision-making. Enter IHD Cloud, a cutting-edge solution designed to centralize and streamline data access, enabling seamless collaboration and enhanced efficiency. We spoke […]
How Unstructured EMR Data Helps Pharma Find Patients
As therapies have become more complex, pharma companies are now challenged to achieve precision targeting within a much tighter timeframe. While claims data is readily available, one of its key limitations is the lack of timeliness. Many manufacturers now rely on specialized lab data—from imaging results to genetic testing and genomics—to identify eligible patients and […]
Harnessing the Power of Real-World Data: How IHD and IHD Cloud Accelerate Insights
Today’s life sciences companies need efficient ways to turn real-world data into meaningful insights. To explore how Panalgo’s Instant Health Data (IHD) and IHD Cloud help organizations streamline analytics and enhance collaboration, we caught up with Matthew Marshall, Solutions Architect at Panalgo. He explains how these tools simplify data analysis, democratize access to insights, and […]
Need for Speed: How Panalgo + Atropos Health Powers Faster Insights for Life Sciences
In June, Panalgo teamed up with Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care. The partnership brings together 35 years of evidence generation, technology, and data experience, redefining speed to insight for the industry. In the first of a series of planned initiatives, Panalgo Instant Health Data (IHD) customers […]
Treatment of Anxiety and Depression in Pregnancy – What do the Data Tell Us?
Treating anxiety and depression during pregnancy is a complex and crucial aspect of maternal healthcare. There are extensive data available on the safety of anti-anxiety and anti-depressant medications for pregnant women, and registries and database studies also play a role in monitoring drug safety. We caught up with Meg Richards, PhD, MPH, Executive Director, Scientific […]